Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Manal Rayyan/LinkedIn
Jul 28, 2026, 13:46

Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance

Manal Rayyan, Adjunct Assistant Professor at United Arab Emirates University, Senior Clinical Pharmacist at SEHA Tawam Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:

“I’m pleased to share our latest publication:

‘Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with haemophilia A: A single-centre experience from the UAE.’

Conducted at Tawam Hospital, this study shows excellent real-world outcomes after switching to once-weekly efanesoctocog alfa prophylaxis, with all patients achieving zero annualized bleeding rate (ABR) and demonstrating a strong safety profile.

I’m grateful to my co-authors and colleagues for their collaboration and commitment to improving care for children with bleeding disorders.

Congratulations to the entire team!”

Title: Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with severe and moderate haemophilia a: A single-centre experience from the United Arab Emirates

Authors: Muhammad Faisal Khanani, Najam Awan, Haydar Alrufaey, Manal Ryan

Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Stay updated on all scientific advances with Hemostasis Today.

Blood Efanesoctocog Haydar Alrufaey Health Hematology Hemostasis Hemostasis News Hemostasis Today Manal Rayyan Medicine Muhammad Faisal Khanani Najam Awan
NewsFeed